| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |